Aspects of the disclosure relate to compositions and methods useful for treating Huntington s disease. In some embodiments, the disclosure provides interfering nucleic acids (e.g., artificial miRNAs) targeting the huntingtin gene (HTT) and methods of treating Huntingtons disease using the same.